Enokizumab Antibody
Enokizumab (MEDI-528) is a humanized monoclonal antibody targeting interleukin-9 (IL-9) . It serves as a key research tool for investigating the role of IL-9 in asthma pathogenesis, utilized in both in vitro cellular assays and in vivo preclinical models of allergic airway disease.
Product Specifications
Product Name Alternative
IL-9, ILReceptor, IL Receptor, MEDI 528, MEDI528, MEDI-528, Enokizumab
Target
Interleukin, IL Receptor
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
3.69 mg/mL
Purity
99.23% (May vary between batches)
Molecular Weight
145.98 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470012-500 1x 500 µL
Tyrosinase (T311), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470050-100 1x 100 µL
IgA Secretory Component (SC05), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882550-100 1x 100 µL
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042385-100 1x 100 µL
CD14 (Monocyte / Macrophage Marker) (LPSR/2385), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details